Orris

Pathophysiology of COPD

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Pulmonary Disease, Chronic Obstructive"[MeSH Terms] AND pathophysiology

Searching the Web

COPD pathophysiology GOLD report airway inflammation emphysema official

Reading File
Reading File
Reading Web Page

https://goldcopd.org/digital-gold-report

Pathophysiology of COPD

COPD results from a chronic, abnormal inflammatory response of the lungs to noxious inhaled particles or gases, most commonly tobacco smoke. Biomass-fuel smoke, air pollution, occupational dusts, and alpha-1 antitrypsin deficiency can also contribute.
The persistent airflow obstruction arises from a variable combination of:
  1. Small-airway disease: chronic bronchitis and obstructive bronchiolitis
  2. Alveolar destruction: emphysema
The current GOLD report describes the central process as chronic inflammation causing small-airway narrowing plus parenchymal destruction, leading to gas trapping and progressively limited expiratory airflow. GOLD pathophysiology overview

Sequence of events

Inhaled irritants
↓
Chronic airway and alveolar inflammation
↓
Mucus hypersecretion, airway-wall remodeling, fibrosis, and alveolar destruction
↓
Loss of elastic recoil and expiratory airway collapse
↓
Air trapping, hyperinflation, impaired gas exchange, and progressive airflow limitation

1. Chronic inflammation

Cigarette smoke and other irritants activate airway epithelial cells and recruit inflammatory cells, particularly:
  • Macrophages
  • Neutrophils
  • CD8+ cytotoxic T lymphocytes
  • In some people, eosinophils also contribute
These cells release inflammatory mediators, oxidants, and proteases such as neutrophil elastase and matrix metalloproteinases. This produces persistent tissue injury and abnormal repair.

2. Small-airway disease

In bronchioles, chronic inflammation causes:
  • Edema and wall thickening
  • Goblet-cell and mucous-gland hyperplasia
  • Excess mucus secretion and impaired mucociliary clearance
  • Mucus plugging
  • Smooth-muscle changes
  • Peribronchiolar fibrosis and narrowing
  • Loss or obliteration of small airways
These changes increase airway resistance. During expiration, especially forced expiration, narrowed bronchioles obstruct airflow.

3. Emphysema: protease-antiprotease and oxidant injury

Proteases released by inflammatory cells digest elastin and other extracellular-matrix components in alveolar walls. Normally, alpha-1 antitrypsin protects lung tissue by inhibiting neutrophil elastase.
Smoking worsens this imbalance by:
  • Increasing protease release
  • Generating oxidants that directly damage tissue
  • Functionally inactivating alpha-1 antitrypsin
  • Impairing repair mechanisms
This causes destruction of alveolar septa and pulmonary capillary beds, with permanent enlargement of distal air spaces, namely emphysema. In alpha-1 antitrypsin deficiency, unchecked elastase activity can cause early, often panacinar emphysema.

4. Loss of elastic recoil and dynamic airway collapse

Alveolar walls normally provide radial traction that keeps small bronchioles open during expiration. With emphysema:
  • Alveolar attachments to bronchioles are lost.
  • Elastic recoil falls.
  • Small airways collapse prematurely during expiration.
Therefore, air can enter relatively more easily than it can leave. This is the basis of persistent expiratory airflow limitation.

5. Air trapping and hyperinflation

Premature expiratory airway closure retains air behind obstructed bronchioles:
  • Static hyperinflation develops over time because residual volume rises.
  • Dynamic hyperinflation occurs during exercise or tachypnea, when the next inspiration begins before full expiration is completed.
Hyperinflation flattens the diaphragm and places inspiratory muscles at a mechanical disadvantage. It is a major cause of exertional dyspnea.

6. Impaired gas exchange

Gas exchange becomes abnormal due to:
  • Ventilation-perfusion mismatch from uneven airway obstruction
  • Loss of alveolar-capillary surface area in emphysema
  • Reduced diffusing capacity, particularly in emphysema
  • Hypoventilation in advanced disease
This initially causes hypoxemia. In severe COPD, carbon dioxide retention can occur, producing hypercapnic respiratory failure.

7. Pulmonary hypertension and cor pulmonale

Chronic hypoxemia causes pulmonary arteriolar vasoconstriction. Along with loss of pulmonary capillary beds and vascular remodeling, this increases pulmonary vascular resistance and may lead to:
  • Pulmonary hypertension
  • Right ventricular hypertrophy
  • Right-sided heart failure, or cor pulmonale

8. Systemic effects

COPD is not confined to the lungs. Chronic inflammation, inactivity, hypoxemia, and increased work of breathing contribute to:
  • Skeletal-muscle dysfunction and wasting
  • Weight loss/cachexia
  • Osteoporosis
  • Cardiovascular comorbidity
  • Anxiety and depression

One-line summary

COPD is caused by chronic inflammation from inhaled irritants that produces mucus plugging and fibrotic narrowing of small airways together with protease- and oxidant-mediated alveolar destruction; the resulting loss of elastic recoil causes expiratory airway collapse, air trapping, hyperinflation, and impaired gas exchange.
Textbook basis: Robbins & Kumar Basic Pathology, COPD section, p. 447.
This is a shared conversation. Sign in to Orris to start your own chat.